483 Primus dba Trinity Biotech Sep 2018

483 Primus dba Trinity Biotech Sep 2018

Eric Fox FDA$119.00 - Available Now

FDA investigators audited the Primus dba Trinity Biotech - Kansas City, MO, United States facility and issued inspectional observations (via FDA 483) on 06 Sep 2018.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 06 Sep 2018
  • Location: Kansas City, United States
  • FEI: 1931251
Add To Cart